2021 | | Implications of tamoxifen resistance in palbociclib efficacy for patients with hormone receptor-positive, her2-negative metastatic breast cancer: Subgroup analyses of kcsg-br15-10 (youngpearl) | 강석윤 |
2021 | | Incident type 2 diabetes risk of selective estrogen receptor modulators in female patients with breast cancer | 최용원 |
2019 | | Increased CMTM6 can predict the clinical response to PD-1 inhibitors in non-small cell lung cancer patients | 고영화, 이현우, 정준호, 한재호, 함석진 |
2000 | | Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. | 김현수, 김효철, 남동기, 이기범, 임호영, 주희재, 최진혁 |
1998 | | Increased serum levels of transforming growth factor-alpha in patients with colorectal cancer. | 최진혁 |
2016 | | Indolent NK cell proliferative lesion mimicking NK/T cell lymphoma in the gallbladder | 박준성, 임현이, 정성현, 한재호 |
2022 | | Induction Chemotherapy as a Prognostication Index and Guidance for Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: The Concept of Chemo-Selection (KCSG HN13-01) | 최진혁 |
2013 | | Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients. | 박준성 |
2014 | | Inhibition of bladder cancer invasion by Sp1-mediated BTG2 expression via inhibition of DNA methyltransferase 1. | 김선일, 김세중, 신승수, 유민숙, 임인경, 임현이, 최용원 |
2004 | | Inhibition of N-(4-hydroxyphenyl)retinamide-induced apoptosis in breast cancer cells by galectin-3. | 최진혁 |
2023 | | Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study | 박준성 |
2010 | | International Comparison of the Eligibility Criteria for Apheresis Donors | 박서진, 박준성, 임영애 |
2018 | | Intracellular formyl peptide receptor regulates naive CD4 T cell migration | 박준성 |
2023 | | Intrinsic and Extrinsic Transcriptional Profiles That Affect the Clinical Response to PD-1 Inhibitors in Patients with Non–Small Cell Lung Cancer | 고영화, 변혜은, 이현우, 한재호, 함석진 |
2019 | | Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma | 이현우 |
2018 | | Investigating the feasibility of targeted next-generation sequencing to guide the treatment of head and neck squamous cell carcinoma. | 이현우 |
2015 | | Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer? | 강석윤, 박준성, 안미선, 이순영, 이현우, 정성현, 최용원, 최진혁 |
2002 | | Is postoperative radiotherapy useful for the rectal carcinoma in the era of total mesorectal excision? | 서광욱, 임호영, 전미선 |
1996 | | Laboratory Findings in Initial Presentation of Iron Deficiency Anemia | 김효철 |
2024 | | Lazertinib versus Gefitinib as First-Line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset | 최진혁 |